Potential clinical applications of C-reactive protein. 1990

J M Okamura, and J M Miyagi, and K Terada, and Y Hokama
John A. Burns School of Medicine, University of Hawaii, Manoa, Honolulu 96822.

This article reviews the clinical applications of C-reactive protein (CRP). This acute-phase protein is a distinct and sensitive marker for inflammation and tissue injury. It is a simple, fast, and relatively inexpensive latex agglutination test. The aspects of CRP reviewed include diagnostic support, serial measurements to evaluate disease course and therapeutic response, and screening studies.

UI MeSH Term Description Entries
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000210 Acute-Phase Reaction An early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma. Acute Phase Response,Acute-Phase State,Reaction, Acute-Phase,Response, Acute-Phase,Acute Phase Reaction,Acute Phase Responses,Acute Phase State,Acute-Phase Response,Phase Response, Acute,Reaction, Acute Phase,Response, Acute Phase,State, Acute-Phase
D000372 Agglutination Tests Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed) Agglutination Test,Test, Agglutination,Tests, Agglutination
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

J M Okamura, and J M Miyagi, and K Terada, and Y Hokama
August 1997, The Pediatric infectious disease journal,
J M Okamura, and J M Miyagi, and K Terada, and Y Hokama
January 2013, Revista da Associacao Medica Brasileira (1992),
J M Okamura, and J M Miyagi, and K Terada, and Y Hokama
December 1958, Il Lattante,
J M Okamura, and J M Miyagi, and K Terada, and Y Hokama
December 1956, L'union medicale du Canada,
J M Okamura, and J M Miyagi, and K Terada, and Y Hokama
February 2008, Vascular medicine (London, England),
J M Okamura, and J M Miyagi, and K Terada, and Y Hokama
January 2009, American journal of cardiovascular drugs : drugs, devices, and other interventions,
J M Okamura, and J M Miyagi, and K Terada, and Y Hokama
February 2022, Veterinary clinical pathology,
J M Okamura, and J M Miyagi, and K Terada, and Y Hokama
March 1958, Ugeskrift for laeger,
J M Okamura, and J M Miyagi, and K Terada, and Y Hokama
June 1957, La Riforma medica,
J M Okamura, and J M Miyagi, and K Terada, and Y Hokama
July 1957, Minerva medica,
Copied contents to your clipboard!